Concepedia

D. Chakrabarti

DC

5

Publications

240

Citations

5

H-Index

1993

Active since

Affiliations

Pfizer (United States)(Current)

D. Chakrabarti is an author at Pfizer (United States) specializing in medicine, autoimmunity, and antibody biology.

Top concepts

Publications per year

1993–2016

5

Publications

5

Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma

Yoon‐Koo Kang, Thomas Yau, J.-W. Park et al. · Annals of Oncology · 2015 · 103 citations · Full text

, , +7

IFN-α induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2

D. Chakrabarti, Barbara A. Hultgren, T.A. Stewart · The Journal of Immunology · 1996 · 94 citations · Full text

Cloning and Expression of a cDNA-Encoding the Homologue of Ran/TC4 GTP-Binding Protein from Plasmodium falciparum

F. Dontfraid, D. Chakrabarti · Biochemical and Biophysical Research Communications · 1994 · 16 citations

, , +7

A multicentre, international, randomised, open-label phase 3 trial of avelumab + best supportive care (BSC) vs BSC alone as maintenance therapy after first-line platinum-based chemotherapy in patients with advanced urothelial cancer (JAVELIN bladder 100)

Thomas Powles, Petros Grivas, Jeanny B. Aragon‐Ching et al. · Annals of Oncology · 2016 · 14 citations · Full text

Immunoregulation by processed immunoglobulin on B-cells.

Ghosh Sk, D. Chakrabarti · PubMed · 1993 · 13 citations

, , +15

Rows per page

1–5 of 5